Get the Stockscreener App
1.76
0.56%
-0.01
After Hours:
1.75
-0.01
-0.57%
Cocrystal Pharma Inc stock is traded at $1.76, with a volume of 10,404.
It is down -0.56% in the last 24 hours and down -2.22% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
See More
Previous Close:
$1.77
Open:
$1.74
24h Volume:
10,404
Relative Volume:
0.52
Market Cap:
$18.06M
Revenue:
-
Net Income/Loss:
$-18.02M
P/E Ratio:
-0.7686
EPS:
-2.29
Net Cash Flow:
$-16.30M
1W Performance:
-1.68%
1M Performance:
-2.22%
6M Performance:
+25.71%
1Y Performance:
-5.88%
1-Day Range:
$1.72
$1.7788
1-Week Range:
$1.62
$1.85
52-Week Range:
$1.325
$3.10
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Cocrystal Pharma commences next phase of antiviral study - Investing.com
Cocrystal Pharma commences next phase of antiviral study By Investing.com - Investing.com Canada
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts - The Manila Times
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose - EIN News
Corover Secures $4 Mn In Series A Funding Led By Venture Catalysts - BW Disrupt
K2 Principal Fund L.P. Takes $1.17 Million Position in CSLM Acquisition Corp. (NASDAQ:CSLM) - Defense World
Coherent Corp (COHR) rating reiterates by Needham - Knox Daily
Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Corcel shares drop as explorer raise funds and ups exposure in Angola - Proactive Investors USA
Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Corcel PLC Bolsters Angola Position with Increased Stake and Funding - TipRanks
Corcel (LON:CRCL) Trading 2.6% Higher - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World
Bearish block trade of CSPC PHARMA(01093) 768K shares at $4.94, $3.794M turnover - AASTOCKS.com
CorVel Co. (NASDAQ:CRVL) Shares Acquired by Kayne Anderson Rudnick Investment Management LLC - MarketBeat
Coherent (COHR) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Momentum Is Driving Corning Stock Higher (NYSE:GLW) - Seeking Alpha
Corbus stock reiterates Outperform rating despite trial data - Investing.com
Cosmic CRF shares hit 5% upper circuit on Rs 127-crore order win; details - Business Standard
Coherent Corp (COHR)’s Market Momentum: Closing Strong at 80.98, Up 3.93 - The Dwinnex
Corning’s stock rises as it sticks to Q3 profit view - MarketWatch
COHR’s Wild Ride: Up 82.75% – What’s Next for COHR? - The InvestChronicle
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.1% - Defense World
CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors - Morningstar
Commonwealth Equity Services LLC Has $996,000 Holdings in Compass Diversified (NYSE:CODI) - Defense World
Examining the Potential Price Growth of CoreCivic Inc (CXW) - Knox Daily
Coherent (NYSE:COHR) delivers shareholders stellar 135% return over 1 year, surging 6.3% in the last week alone - Yahoo Finance
Prepare Yourself for Liftoff: Coherent Corp (COHR) - SETE News
Coherent Corp (COHR) receives a Buy rating from Needham - Knox Daily
Hollyland Cosmo C2 Wireless Video System First Look - Newsshooter
State of New Jersey Common Pension Fund D Lowers Stock Holdings in Sea Limited (NYSE:SE) - Defense World
LPL Financial LLC Has $46.81 Million Stake in iShares Fallen Angels USD Bond ETF (NASDAQ:FALN) - Defense World
CoreCivic Inc [CXW] stock for 106,240 USD was sold by Carter, Cole G. - Knox Daily
Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG - Barchart
Titan Pharma (NASDAQ:TTNP) Stock Quotes, Forecast and News Summary - Benzinga
Cocrystal Pharma (NASDAQ:COCP) PT Lowered to $7.00 at HC Wainwright - Defense World
Toll Brothers To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Cocrystal Pharma stock target cut on Phase 1 results - Investing.com
Cocrystal Pharma stock target cut on Phase 1 results By Investing.com - Investing.com UK
Cocrystal Pharma, Inc. to Post FY2024 Earnings of ($2.12) Per Share, Zacks Small Cap Forecasts (NASDAQ:COCP) - Defense World
Cocrystal Pharma Engages Investors at Upcoming Conferences - TipRanks
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences - ForexTV.com
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences - StockTitan
Noble Financial Weighs in on Cocrystal Pharma, Inc.’s FY2024 Earnings (NASDAQ:COCP) - Defense World
AGBA Group Holding Limited (NASDAQ:AGBAW) Short Interest Down 7.6% in July - Defense World
Zacks Research Weighs in on Anheuser-Busch InBev SA/NV’s Q3 2024 Earnings (NYSE:BUD) - Defense World
Noble Financial Comments on Cocrystal Pharma, Inc.’s Q3 2024 Earnings (NASDAQ:COCP) - Defense World
HC Wainwright Brokers Raise Earnings Estimates for Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) - Defense World
Atyr PHARMA INC (NASDAQ:ATYR) to Post Q3 2024 Earnings of ($0.22) Per Share, HC Wainwright Forecasts - Defense World
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event - Lelezard
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):